Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CareDx Q2 2024 Adj. EPS $0.25 Beats $(0.14) Estimate, Sales $92.274M Beat $67.861M Estimate

Author: Benzinga Newsdesk | July 31, 2024 04:37pm
CareDx (NASDAQ:CDNA) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $(0.14) by 278.57 percent. This is a 238.89 percent increase over losses of $(0.18) per share from the same period last year. The company reported quarterly sales of $92.274 million which beat the analyst consensus estimate of $67.861 million by 35.98 percent. This is a 31.26 percent increase over sales of $70.301 million the same period last year.

Posted In: CDNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist